Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02987803 · ClinicalTrials.gov registry record · NA
Helping Mothers Select Better Childbirth Hospitals
A NA study, sponsored by Harvard School of Public Health (HSPH).
- Completed
- Registry status
- NA
- Development phase
- 120,621
- Enrollment target
NCT02987803: Completed NA study, sponsored by Harvard School of Public Health (HSPH).
NCT02987803 is a NA study that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 120,621 participants, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (8503% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02987803, a NA study, has completed, sponsored by Harvard School of Public Health (HSPH).
- COMPLETED
- Registry status
- NA
- Development phase
- 120,621 participants
- Enrollment target
Study Summary
The investigators aim to conduct a randomized controlled trial of women who are pregnant or considering pregnancy to understand whether women provided with specific data on hospital-level cesarean delivery rates are more likely to select higher quality hospitals, defined as hospitals with cesarean delivery rates below the Federal HealthyPeople 2020 target of 23.9%.
Primary Outcome
Enrollees will be asked to self-report the hospital where they delivered. Hospitals will be categorized into a five-star quality rating scale based on the corresponding quintile of their cesarean section rate at the state level, as reported to the Leapfrog Group and other state data sources. Our primary outcome will be the average star rating of hospitals selected by control and intervention group enrollees. We will also report the proportion of enrollees in each group selecting hospitals of eac
Interventions
- OTHER Data
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120,621 participants |
| Start Date | 2019-08-15 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
What the finished NCT02987803 record still lists
NCT02987803 is an interventional study that assigns participants to a tested intervention. Its 120,621 participants enrollment target places it among the larger protocols in the corpus, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (8503% higher).
The record links to 0 conditions, and to 1 intervention - of which Data is the first listed.
NCT02987803 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02987803 about?
NCT02987803 is a clinical study titled "Helping Mothers Select Better Childbirth Hospitals". The investigators aim to conduct a randomized controlled trial of women who are pregnant or considering pregnancy to understand whether women provided with specific data on hospital-level cesarean delivery rates are more likely to select higher quality hospitals, defined as hospitals with cesarean d...
What is the current status of trial NCT02987803?
This trial is currently completed. It is a NA study. The enrollment target is 120,621 participants. The study started on 2019-08-15. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT02987803?
The interventions under investigation include: Data (OTHER).
Who is sponsoring clinical trial NCT02987803?
This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02987803's enrollment target sits among peer trials
120,621 2nd of 2000 the highest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897374 · 120,000 participants
Strategic Targeting for Optimal Prevention of Cancer
- NCT06608758 · 120,000 participants
End Diagnostic Overshadowing:Addressing Ableism in Diagnoses
- NCT06251323 · 119,680 participants · NA
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
- NCT02693509 · 128,026 participants
Get With The Guidelines-Heart Failure Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI